Research programme: antibacterials - Quorex Pharmaceuticals
Alternative Names: QX5-1646 series antibacterials - Quorex; QX5-1799 series antibacterials - Quorex; QX5-1809 series antibacterials - QuorexLatest Information Update: 25 May 2010
Price :
$50 *
At a glance
- Originator Quorex Pharmaceuticals
- Class Small molecules
- Mechanism of Action DNA gyrase inhibitors; FabH inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 25 May 2010 No development reported - Preclinical for Bacterial infections in USA (unspecified route)
- 12 Jul 2004 This programme is still in active development - BIO 2004 Annual International Convention (BIO-2004)
- 30 Jan 2003 This programme is still in active development